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can bind to either ankyrin in vitro, what makes the channels preferentially bind to ankyrin G in vivo?
To answer this question, Bréchet et al. homed in on the precise residues in sodium channels that 
are required for the interaction with ankyrin G. They pinpointed a sequence of residues that looked 
like a target for phosphorylation by CK2, and sure enough, it was. CK2 phosphorylated the sodium 
channels and this was required for the channels’ correct positioning along the axon membrane.
In vitro, however, phosphorylation by CK2 prompted the channels to bind both ankyrin G 
and B. The clue to the sodium channels’ specifi  city for ankyrin G came when the team looked at 
the distribution of CK2 in neurons and found that it was also restricted to the AIS and the nodes of 
Ranvier. The big question now is, what targets CK2? RW
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FHL1 adds some muscle
Cowling et al. report how to build muscle mass with FHL1. The protein partners with and activates 
the transcription factor, NFATc1. Encouraging this partnership might provide a possible treatment for 
muscle wasting disorders.
Mutations in FHL1 are present in several myopathies, including reducing-body myopathy 
(RBM), but until now, both the molecular mechanisms causing the disease, and the regular function 
of FHL1 in healthy tissue, remained unknown.
To address this, Cowling et al. overexpressed FHL1 in both transgenic mice and cultured 
myoblasts. The mice developed skeletal muscle hypertrophy, and showed increased strength and 
endurance. Overexpression in myoblasts also increased cell fusion, resulting in hypertrophic 
myotubes. These phenotypes are similar to those caused by the calcineurin/NFAT pathway and, 
indeed, inhibiting calcineurin blocked the effects of FHL1 overexpression in vitro. The authors 
showed that FHL1 binds to and enhances the transcriptional activity of NFATc1 in vitro and in vivo.
So what goes wrong when FHL1 is mutated? In RBM, mutant FHL1 accumulates in cytoplasmic 
aggregates called reducing bodies, probably as a result of misfolding. When these mutants were 
expressed in cultured myoblasts, they also aggregated, and did not induce hypertrophy. Cowling and 
colleagues found that NFATc1 was sequestered to the aggregates, and was therefore unable to activate 
its target genes. BS
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The actin flow paradox
Gardel et al. have discovered a perplexing anomaly regarding actin dynamics and cell traction on its 
extracellular matrix.
In a migrating cell, actin fi  laments polymerize at the leading edge, and fl  ow back into the body of 
the cell (retrograde fl  ow). It has been proposed that focal adhesions (FAs)—the cell’s tether points to 
the extracellular matrix (ECM)—forming at the cell’s leading edge provide handholds for the fl  owing 
actin that impede actin’s retrograde movement, and in so doing create the traction needed to push the 
cell forward. The situation might be likened to a crowd of people being washed downriver and certain 
individuals gripping rocks (FAs) on the riverbed to work their way back against the fl  ow.
Gardel et al. hypothesized that the speed of actin retrograde fl  ow should be inversely correlated 
to traction force—the slower the river fl  ows, the easier it is to grip the rocks and work one’s way 
upstream—and indeed, this is exactly what they discovered. However, this was only true for the 
actin speeds seen at the front end of the cell (10–30 nm per second). At the frontal tip (where FAs are 
small), actin retrograde fl  ow was rapid and traction was minimal. A little farther back in the leading 
edge (where FAs are bigger), traction increased and actin speeds slowed. Back toward the cell body, 
however, despite actin speeds dropping below 8–10 nm per second, the FAs exerted less traction.
Clare Waterman, who led the study, explains that the switch occurs roughly in the area where 
the lamellipodia (leading edge) ends, and the cell body begins. There must therefore be something 
different about the way the FAs and actin combine to generate tension in this region. RW
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Unlike the wild-type protein (left), 
mutant FHL1 (right, green) forms 
cytosolic aggregates (arrows) that
sequester NFATc1 (red).
Actin speed (red) at the cell’s leading 
edge has a biphasic relationship with
cell traction.